Investegate |Jeito Capital Announcements | Jeito Capital: Jeito Capital becomes a significant investor in HI-Bio, a clinical-stage biotech company developing targeted therapies for patients with severe immune-mediated diseases

Investegate announcements from Jeito Capital, Jeito Capital becomes a significant investor in HI-Bio, a clinical-stage biotech company developing targeted therapies for patients with severe immune-mediated diseases

Related Keywords

United States ,Paris ,France General ,France ,Assia Mouhout ,Travis Murdoch ,Rachel Mears ,Linkedin ,Twitter ,Consilium Strategic Communications ,Jeito Capital ,Monograph Capital ,San Francisco Based ,Human Immunology Biosciences ,Jane Elliott ,Davide Salvi ,Investegate Announcements ,Investegate Company Announcements ,Lobenewswire ,Lobenewswire And Globenewswire ,Nw ,